Page last updated: 2024-08-21

adamantane and Liver Failure, Acute

adamantane has been researched along with Liver Failure, Acute in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hu, X; Jiang, R; Jiang, X; Ling, Q; Liu, H; Liu, Y; Wan, J; Wu, Q; Yan, L; Zhang, S	1

Other Studies

1 other study(ies) available for adamantane and Liver Failure, Acute

Article	Year
CQMUH-011, a novel adamantane sulfonamide compound, inhibits lipopolysaccharide- and D-galactosamine-induced fulminant hepatic failure in mice. International immunopharmacology, 2017, Volume: 47 Topics: Adamantane; Animals; Anti-Inflammatory Agents; Galactosamine; Lipopolysaccharides; Liver Failure, Acute; Macrophages; Male; Mice; Mice, Inbred BALB C; NF-kappa B; RAW 264.7 Cells; Signal Transduction; Sulfonamides; Toll-Like Receptor 4	2017

Article

Year

CQMUH-011, a novel adamantane sulfonamide compound, inhibits lipopolysaccharide- and D-galactosamine-induced fulminant hepatic failure in mice.

International immunopharmacology, 2017, Volume: 47

Topics: Adamantane; Animals; Anti-Inflammatory Agents; Galactosamine; Lipopolysaccharides; Liver Failure, Acute; Macrophages; Male; Mice; Mice, Inbred BALB C; NF-kappa B; RAW 264.7 Cells; Signal Transduction; Sulfonamides; Toll-Like Receptor 4

2017